DK536677A - 5- (SUBSTITUTED PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOG AND PROCEDURE FOR THE PREPARATION - Google Patents

5- (SUBSTITUTED PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOG AND PROCEDURE FOR THE PREPARATION

Info

Publication number
DK536677A
DK536677A DK536677A DK536677A DK536677A DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A DK 536677 A DK536677 A DK 536677A
Authority
DK
Denmark
Prior art keywords
oxazolidinones
procedure
preparation
substituted phenyl
sulfur analog
Prior art date
Application number
DK536677A
Other languages
Danish (da)
Other versions
DK149850B (en
DK149850C (en
Inventor
A Huth
R Schmiechen
W Kehr
G Paschelke
H Wachtel
H H Schneider
D Palenschat
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19762655369 external-priority patent/DE2655369A1/en
Priority claimed from DE19772745320 external-priority patent/DE2745320A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK536677A publication Critical patent/DK536677A/en
Publication of DK149850B publication Critical patent/DK149850B/en
Application granted granted Critical
Publication of DK149850C publication Critical patent/DK149850C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
DK536677A 1976-12-03 1977-12-02 METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES DK149850C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19762655369 DE2655369A1 (en) 1976-12-03 1976-12-03 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION
DE2655369 1976-12-03
DE19772745320 DE2745320A1 (en) 1977-10-05 1977-10-05 5-Alkoxyphenyl-oxazolidine-2-one and sulphur analogues - useful as neuroleptics and phospho-di:esterase inhibitors
DE2745320 1977-10-05

Publications (3)

Publication Number Publication Date
DK536677A true DK536677A (en) 1978-06-04
DK149850B DK149850B (en) 1986-10-13
DK149850C DK149850C (en) 1987-04-27

Family

ID=25771221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK536677A DK149850C (en) 1976-12-03 1977-12-02 METHOD OF ANALOGUE FOR THE PREPARATION OF 5- (3,4-DISUBST. PHENYL) -OXAZOLIDINONES OR THIAZOLIDINONES OR THE SIMILAR THIONES

Country Status (19)

Country Link
JP (1) JPS5382777A (en)
AT (1) AT357529B (en)
AU (1) AU519994B2 (en)
CA (1) CA1097657A (en)
CH (1) CH635578A5 (en)
CS (1) CS199694B2 (en)
DD (1) DD133667A5 (en)
DK (1) DK149850C (en)
FR (1) FR2372814A1 (en)
GB (1) GB1588639A (en)
GR (1) GR64964B (en)
HU (1) HU175676B (en)
IE (1) IE46435B1 (en)
IL (1) IL53520A (en)
IT (1) IT1089341B (en)
LU (1) LU78616A1 (en)
NL (1) NL7713153A (en)
SE (1) SE441446B (en)
SU (1) SU888821A3 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2701215C2 (en) * 1977-01-13 1982-10-14 Bayer Ag, 5090 Leverkusen Process for the preparation of thiazoline-2-thiones
US4348393A (en) * 1978-06-09 1982-09-07 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
DE3438839A1 (en) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen PHARMACEUTICAL PREPARATIONS
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
WO1987006576A1 (en) * 1986-04-29 1987-11-05 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
JPH01135098U (en) * 1988-03-11 1989-09-14
WO1991007177A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
US5461056A (en) * 1992-05-08 1995-10-24 Pfizer Inc. Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
ATE260911T1 (en) * 1993-12-22 2004-03-15 Celltech R&D Ltd TRISUBSUTITUTED PHENYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PHOSPHODIESTERASE (TYPE IV) INHIBITORS
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412571D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412573D0 (en) * 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
JP2001507349A (en) 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) * 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
LU78616A1 (en) 1978-04-20
SE441446B (en) 1985-10-07
AU3117577A (en) 1979-06-07
DK149850B (en) 1986-10-13
DK149850C (en) 1987-04-27
GR64964B (en) 1980-06-10
NL7713153A (en) 1978-06-06
IT1089341B (en) 1985-06-18
JPS5382777A (en) 1978-07-21
FR2372814B1 (en) 1980-10-10
CA1097657A (en) 1981-03-17
FR2372814A1 (en) 1978-06-30
JPS6154792B2 (en) 1986-11-25
CH635578A5 (en) 1983-04-15
IE46435B1 (en) 1983-06-15
SE7713635L (en) 1978-06-04
AT357529B (en) 1980-07-10
CS199694B2 (en) 1980-07-31
SU888821A3 (en) 1981-12-07
IL53520A0 (en) 1978-03-10
IE772446L (en) 1978-06-03
IL53520A (en) 1981-07-31
GB1588639A (en) 1981-04-29
AU519994B2 (en) 1982-01-07
ATA868677A (en) 1979-12-15
DD133667A5 (en) 1979-01-17
HU175676B (en) 1980-09-28

Similar Documents

Publication Publication Date Title
DK536677A (en) 5- (SUBSTITUTED PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOG AND PROCEDURE FOR THE PREPARATION
DK470277A (en) LIPROSOMS CONTAINING HEPARIN AND THE PROCEDURE FOR THEIR PREPARATION
FR2461870B1 (en) REGULATING VALVE
DK528979A (en) SILICAGELES PROCEDURE FOR THEIR MANUFACTURING AND THEIR USE
DK397777A (en) THIAZOLINE INDIVATIVES AND PROCEDURES FOR THE PREPARATION
DK47376A (en) BENZOYLUREIDO-NITRO-DIPHENYLETHERS AND THE PROCEDURE FOR THEIR PREPARATION AND USE
DK357677A (en) BERERFIXED ENZYMES AND THE PROCEDURE FOR MANUFACTURE AND USE
DK540678A (en) POLYPEPTIDES AND PROCEDURES FOR THE PREPARATION
DK194377A (en) PYRROLIDONES AND THEIR MANUFACTURE AND USE
DK21079A (en) SUBSTITUTED HETEROCYCLOSE BENZAMIDS AND PROCEDURES FOR THE MANUFACTURE
DK358678A (en) 1,4-BIS-AMINO-ANTHRAQUINON COMPOUNDS AND THEIR USE AND MANUFACTURE
DK407577A (en) AZABICYCLO COMPOUNDS AND THEIR MANUFACTURE AND USE
SE7803700L (en) RELE
AT348664B (en) VALVE PROSTHESIS
DK184679A (en) SUBSTITUTED 1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES PROCEDURE FOR THEIR PREPARATION AND THEIR USE
DK97179A (en) BICYCLOOCTAN DERIVATIVES AND THEIR MANUFACTURE AND USE
DK244275A (en) 3- (4-AMINOPIPERAZIN-1-YL-ALKYL) -INDOL COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION AND USE
DK461179A (en) PROCEDURE FOR THE MANUFACTURE OF AZOLYLKETALS AND THEIR USE AS MICROBICIDES
DK375180A (en) MOERTLER FROM INORGANIC BINDING PROCEDURES FOR THE MANUFACTURING THEREOF AND THEIR USE
DK38778A (en) AZACYCLOALKANES AZACYCLOALKENES AND DERIVATIVES THEREOF AND PROCEDURES FOR THE MANUFACTURE
DK206377A (en) SUBSTITUTED PYRAZOLOPYRIMINES PROCEDURE FOR THEIR PREPARATION AND THEIR USE
DK29876A (en) SULFUR-CONTAINING OCTAPEPTI DERIVATIVES AND PROCEDURES FOR THE PREPARATION
DK279777A (en) CARBOSTYRILES AND THEIR MANUFACTURE AND USE
DK279877A (en) 1-ACYLOXY-1-PHENYL-2-AZOLYL-ETHANES PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES AND NEMATODICICIDES
DK72979A (en) PHENYL NITRAMINS WITH FUNGCID EFFECT AND THEIR MANUFACTURE AND USE

Legal Events

Date Code Title Description
PBP Patent lapsed